© Spencerbdavies/pixabay.com

Three small-scale studies hinted at new COVID-19 vaccination boosters not significantly enhancing the immune response to Omicron variant.

Memo Therapeutics used its huMemoMAB platform to develop antibodies to treat cancers and infections. © Memo Therapeutics AG

Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.

Natàlia Mas (ACCIÓ), Robert Fabregat (Biocat), Jaume Amat (CataloniaBio & HealthTech) and Silvia Ondategui (EY), today during the presentation of the 2021 BioRegion Report. © Biocat

Catalonia’s healthcare start-ups raised €238m in 2021, a new record and 4% up from 2020. Four fifth (83%) of VC came from international investors.
   

EU Health Commissioner Stella Kyriakides, archive photo. © European Parliament

The European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.

Audi and Krajete aim at create sustainable next-generation technologies. © AUDI AG

Automotive company Audi AG and gas fermentation specialist Krajete GmbH are building a highly effective industrial-scale CO2 Direct Air Capturing plant in Linz.

Solein protein powder. © Solar Foods

Finnish Solar Foods Ltd has got the first ever novel food authorisation for its microbially-produced protein powder Solein.

In 2020, Catalent took over Bone Therapeutics' tcell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA, including all of its assets located in Gosselies, Belgium. © Bone Therapeutics

Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a €40m deal and changed its name into BioSenic.

 

© Resolve Biosciences

Molecular cartography company Resolve Biosciences has raised $71m in series B funding co-led by Patient Square Capital, EDBI, Alafi Capital and NRW.BANK as well as other existing investors.

© Peter Fraser

Cambridge-based Enhanc3D Genomics Ltd has raised £10m in Series A financing led by BGF and Parkwalk Advisors.

Univercells SA

Belgian CDMO Univercells SA has raised €44m through the first close of its Series D financing round led by Belgian and international investors. I